HER2 negative - Globe Thesis

Keyword [HER2 negative] Result: 1 - 18 \| Page: 1 of 1
1.	Studies On Treatment Of Apatinib In Combination With Oral Vinorelbine In Pretreated HER2-negative Advanced Breast Cancer And Prognostic Prediction In Triple-negative Breast Cancer
2.	Clinical Significance Of Ki-67 On The Efficacy Of Neoadjuvant Chemotherapy For Hormone Receptor Positive HER2 Negative Breast Cancer
3.	Clinical Significance Of Ki-67 And PR In HER2-negative Luminal Type Breast Cancer And Analysis Of Related Factors Of Recurrence And Metastasis
4.	A Retrospective Study On The Expression Of Proliferative And Invasive Genes-Related Protein And Its Value Of Prognosis In ER/PR-Positive And HER2-Negative Breast Cancer
5.	Effect Of Postoperative Chemotherapy On The Prognosis Of Patients With Stage ⅡA-ⅢB HER2-negative Breast Cancer Without PCR After Neoadjuvant Chemotherapy
6.	Efficacy Of Paclitaxel And Albumin-bound Paclitaxel In Neoadjuvant Chemotherapy For Human Epidermal Growth Factor Receptor-2(HER2)Negative Breast Cancer
7.	Survival Analysis Of HR Positive/HER2 Negative Early Breast Cancer With Diverse HER2 Protein Expression Levels
8.	The Study On Efficacy And Mechanism Of Anlotinib In The Treatment Of Metastatic Breast Cancer
9.	Omission Of Chemotherapy In HR+/HER2- Early Invasive Breast Cancer Based On Combined 6-IHC Score Compare With 21 Gene Expression Assay
10.	Value Of Serum VEGFA In Predicting The Efficacy Of First-line Chemotherapy And Survival Outcome In Patients With HER2 Negative Advanced Gastric Cancer
11.	Analysis Of Influencing Factors And Efficacy Prediction Of Neoadjuvant Chemotherapy On HR Positive And HER2 Negative Breast Cancer
12.	A Meta-Analysis Of Cyclin-Dependent Kinase 4/6 Inhibitors In Postmenopausal Patients With Hormone Receptor Positive,HER2-Negative Advanced Breast Cancer
13.	Real World Study Of Albumin Paclitaxel In The Treatment Of HER2 Negative Advanced Breast Cancer
14.	Efficacy And Safety Of CDK4/6 Inhibitors In Hormone Receptor Positive And HER2-negative Advanced Breast Cancer: A Meta-analysis
15.	The Expression And Significance Of The Gene CD68 In Early-Stage HER2-negative Luminal-like Breast Cancer
16.	Analysis Of De Novo And Recurrent Metastatic Breast Cancer With HER2-negative
17.	Observation Of Therapeutic Effect Of "Fuzheng Jiedu Quyu Method" Prescription Plus Chemotherapy As Maintenance Treatment In Patients With Advanced HER2-Negative Gastric Cancer
18.	Characterization And Prognostic Differences Of Different HER2 Expression Status In HER2-negative Breast Cancer Based On Single-center Real-world Clinical And Pathological Indicators
<<First <Prev Next> Last>> Jump to